This was enabled by leveraging Center and other external funds with institutional commitments and resources, as well as the formation of critical partnerships with other units inside and outside the URMC. Collaborative interactions within the Center have been enhanced.

Disease Programs have become increasingly multidisciplinary, cutting-edge scientific advancements have been made, and new directions in basic science and clinical/translational research have been set in motion.

Included in these advancements have been:

• The recruitment of new Center members who enhance and focus critical elements of basic science, as well as facilitate pathways for translational research.
• Expansion of the experimental Inhalation Facilities to include human exposure facilities that advance translational capabilities and are highly permissive for the integration of human studies with animal models.
• Development of a Behavioral Sciences Facility with human and experimental animal capabilities that may permit the integration and bidirectional translation of experimental and clinical research.
• Research on neurological endpoints in environmental health sciences.
• Formalization of long-standing translational programs within the Integrated Health Science Facility Core (IHSFC) that further facilitates translational efforts in partnership with Rochester’s Clinical & Translational Science Institute (CTSI).

Internal Policy Committee

• Thomas A. Gasiewicz, PhD (Director)
• Ned Ballatori PhD (Deputy Director; Co-Director, Pilot Project Program)
• Deborah A. Cory-Slechta, PhD (Co-Director, IHSFC; Director, Career Development Program; Co-Director Animal/Human Behavioral Science Facility; Coordinator, Neurodevelopment and Neurodegenerative Disease Program)
• Philip W. Davidson, PhD (Coordinator, Neurodevelopment and Neurodegenerative Disease Program)
• Jacob N. Finkelstein, PhD (Co-Director, Pilot Project Program)
• Steven N. Georas, MD (Co-Director, IHSFC)
• Dina G. Markowitz, PhD (Director, COEC)
• Pat Noonan (Administrator)
• David Oakes, PhD (Director, Biostatistics Facility Core)
• Günter Oberdörster, DVM, PhD (Co-Director, IHSFC; Co-Director Animal/Human Inhalation Facility; Coordinator, Pulmonary and Cardiovascular Disease Program)
  
• J. Edward Puzas, PhD (Coordinator, Musculoskeletal Disease Program)
• Mark J. Utell, MD (Co-Director, Human/Animal Inhalation Facility

External Policy Committee

• John D. Groopman, PhD, NIEHS Center Director, Johns Hopkins University
• Agnes B. Kane, PhD, Chair, Department of Pathology, Brown University
• Kenneth S. Ramos, PhD, Chair, Department of Biochemistry & Molecular Biology, University of Louisville